Oncosil Medical Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -1.814x

Oncosil Medical Ltd cash flow conversion efficiency. Based on the latest financial reports, Oncosil Medical Ltd (OSL) has a cash flow conversion efficiency ratio of -1.814x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.96 Million ≈ $-4.93 Million USD) by net assets (AU$3.84 Million ≈ $2.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Oncosil Medical Ltd (2005–2025)

Cash flow conversion efficiency of Oncosil Medical Ltd from 2005 to 2025. This chart illustrates how Oncosil Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Oncosil Medical Ltd (OSL) share price today for real-time trading data and today's change.

Oncosil Medical Ltd Cash Flow Conversion Ratio Explained

Oncosil Medical Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Oncosil Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosil Medical Ltd ranked by their cash flow conversion efficiency. Also see Oncosil Medical Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Prodigy Gold NL AU:PRX	-0.311x
Proteomics International Laboratories Ltd AU:PIQ	-0.132x
Energisme PA:ALNRG	-1.376x
Hookipa Pharma Inc NASDAQ:HOOK	-0.249x
IRIDEX Corporation NASDAQ:IRIX	0.048x
Goodyear Lastikleri TAS IS:GOODY	0.150x
Majuperak Holdings Bhd KLSE:8141	-0.009x
Profithol S.A. MC:SPH	-0.745x

Annual Cash Flow Conversion Efficiency for Oncosil Medical Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Oncosil Medical Ltd from 2005 to 2025. Review OSL free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$3.10 Million ≈ $2.20 Million	AU$-12.06 Million ≈ $-8.53 Million	-3.887x	-70.07%
2024-06-30	AU$4.74 Million ≈ $3.35 Million	AU$-10.82 Million ≈ $-7.66 Million	-2.285x	-99.55%
2023-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-11.32 Million ≈ $-8.01 Million	-1.145x	-26.45%
2022-06-30	AU$11.16 Million ≈ $7.90 Million	AU$-10.11 Million ≈ $-7.15 Million	-0.906x	-20.17%
2021-06-30	AU$11.70 Million ≈ $8.28 Million	AU$-8.82 Million ≈ $-6.24 Million	-0.754x	-270.43%
2020-06-30	AU$21.90 Million ≈ $15.50 Million	AU$-4.46 Million ≈ $-3.15 Million	-0.203x	+71.04%
2019-06-30	AU$10.68 Million ≈ $7.55 Million	AU$-7.50 Million ≈ $-5.31 Million	-0.703x	-51.92%
2018-06-30	AU$18.15 Million ≈ $12.85 Million	AU$-8.40 Million ≈ $-5.94 Million	-0.463x	+23.27%
2017-06-30	AU$10.13 Million ≈ $7.17 Million	AU$-6.11 Million ≈ $-4.32 Million	-0.603x	-95.27%
2016-06-30	AU$14.81 Million ≈ $10.48 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.309x	-1155.70%
2015-06-30	AU$6.96 Million ≈ $4.93 Million	AU$-171.16K ≈ $-121.11K	-0.025x	+96.33%
2014-06-30	AU$9.52 Million ≈ $6.73 Million	AU$-6.37 Million ≈ $-4.51 Million	-0.669x	-758.32%
2013-06-30	AU$6.05 Million ≈ $4.28 Million	AU$-471.91K ≈ $-333.90K	-0.078x	+36.67%
2012-06-30	AU$2.48 Million ≈ $1.76 Million	AU$-305.78K ≈ $-216.36K	-0.123x	-13.30%
2011-06-30	AU$2.91 Million ≈ $2.06 Million	AU$-316.67K ≈ $-224.06K	-0.109x	-281.54%
2010-06-30	AU$2.58 Million ≈ $1.82 Million	AU$154.35K ≈ $109.21K	0.060x	+346.60%
2009-06-30	AU$4.28 Million ≈ $3.03 Million	AU$-103.97K ≈ $-73.57K	-0.024x	+95.45%
2008-06-30	AU$4.09 Million ≈ $2.89 Million	AU$-2.18 Million ≈ $-1.54 Million	-0.533x	-85.54%
2007-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.35 Million ≈ $-952.00K	-0.288x	-902.55%
2006-06-30	AU$5.46 Million ≈ $3.86 Million	AU$195.51K ≈ $138.34K	0.036x	+278.21%
2005-06-30	AU$899.56K ≈ $636.50K	AU$-18.08K ≈ $-12.80K	-0.020x	--

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices

Market Cap

$11.45 Million

AU$16.18 Million AUD

Market Cap Rank

#26552 Global

#1201 in Australia

Share Price

AU$0.69

Change (1 day)

+1.48%

52-Week Range

AU$0.39 - AU$1.55

All Time High

AU$1.99